---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-030816"
form_type: "8-K"
ticker: null
cik: "0001008848"
company_name: "Acorda Therapeutics, Inc."
filed_at: "2024-03-13T23:59:59+00:00"
generated_at: "2026-06-04T21:59:04.723040+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Acorda Therapeutics amends Bylaws to enhance director nomination procedures and conform to Delaware law

## Summary
- Board adopted Amended and Restated Bylaws effective March 7, 2024.
- Enhanced disclosure and procedural requirements for stockholder director nominations, including Rule 14a-19 compliance.
- Updated provisions reflect recent amendments to Delaware General Corporation Law.
- Includes clerical and conforming changes.

## SEC filing metadata
- accession: 0000950170-24-030816
- form_type: 8-K
- cik: 0001008848
- company_name: Acorda Therapeutics, Inc.
- filed_at: 2024-03-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1008848/000095017024030816/0000950170-24-030816-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1008848/000095017024030816/acor-20240307.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-030816
- JSON: https://secwatch.observer/filing/0000950170-24-030816.json
- Plain text: https://secwatch.observer/filing/0000950170-24-030816.txt

## Key facts
- Governance Changes
  Acorda Therapeutics, Inc.: Adopted amended and restated bylaws effective immediately, enhancing disclosure and procedural requirements for stockholder director nominations and updating provisions to reflect Delaware law changes (effective 2024-03-07).
  - Change: bylaw amendment
  - Effective: 2024-03-07
  source text: On March 7, 2024, the Board of Directors of Acorda Therapeutics, Inc. (the “Company”) adopted amendments to the Company’s Bylaws (the “Amended and Restated Bylaws”), which became effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1008848/000095017024030816/0000950170-24-030816-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.